Effect of endocrine disruptors on bacterial virulence.

antibiotic tolerance biofilm endocrine disruptors pathogens virulence

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2023
Historique:
received: 11 09 2023
accepted: 23 10 2023
medline: 1 12 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

For several decades, questions have been raised about the effects of endocrine disruptors (ED) on environment and health. In humans, EDs interferes with hormones that are responsible for the maintenance of homeostasis, reproduction and development and therefore can cause developmental, metabolic and reproductive disorders. Because of their ubiquity in the environment, EDs can adversely impact microbial communities and pathogens virulence. At a time when bacterial resistance is inevitably emerging, it is necessary to understand the effects of EDs on the behavior of pathogenic bacteria and to identify the resulting mechanisms. Increasing studies have shown that exposure to environmental EDs can affect bacteria physiology. This review aims to highlight current knowledge of the effect of EDs on the virulence of human bacterial pathogens and discuss the future directions to investigate bacteria/EDs interaction. Given the data presented here, extended studies are required to understand the mechanisms by which EDs could modulate bacterial phenotypes in order to understand the health risks.

Identifiants

pubmed: 38029256
doi: 10.3389/fcimb.2023.1292233
pmc: PMC10657830
doi:

Substances chimiques

Endocrine Disruptors 0
Hormones 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1292233

Informations de copyright

Copyright © 2023 Thiroux, Berjeaud, Villéger and Crépin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Life Sci. 1992;50(3):203-12
pubmed: 1731173
Antimicrob Agents Chemother. 2019 Feb 26;63(3):
pubmed: 30642923
Sci Total Environ. 2018 Sep 1;635:817-827
pubmed: 29710605
Folia Microbiol (Praha). 2023 Jun;68(3):477-488
pubmed: 36635520
PLoS Pathog. 2020 Oct 30;16(10):e1008529
pubmed: 33125434
Environ Health Perspect. 2017 Jun 20;125(6):064501
pubmed: 28632490
PLoS One. 2018 Apr 2;13(4):e0195244
pubmed: 29608622
Virulence. 2022 Dec;13(1):1666-1680
pubmed: 36128741
Sci Rep. 2019 Dec 27;9(1):20203
pubmed: 31882963
BMC Genomics. 2008 Oct 06;9:458
pubmed: 18837991
Sci Total Environ. 2020 Apr 15;713:136621
pubmed: 32019018
Sci Total Environ. 2022 Feb 1;806(Pt 4):150966
pubmed: 34656589
Environ Microbiol Rep. 2023 Dec;15(6):740-756
pubmed: 37586891
J Expo Sci Environ Epidemiol. 2013 Mar;23(2):137-44
pubmed: 22805988
Environ Res. 2019 Nov;178:108692
pubmed: 31520825
Environ Sci Technol. 2022 Jan 18;56(2):1081-1090
pubmed: 34991317
Water Environ Res. 2019 Aug;91(8):715-721
pubmed: 30859670
mBio. 2015 Aug 25;6(4):
pubmed: 26307165
Food Chem Toxicol. 2005 Jul;43(7):985-1015
pubmed: 15833376
Environ Int. 2018 Sep;118:257-265
pubmed: 29902774
J Agric Food Chem. 2016 Nov 23;64(46):8866-8875
pubmed: 27792318
Signal Transduct Target Ther. 2022 Jun 25;7(1):199
pubmed: 35752612
Ecotoxicol Environ Saf. 2015 Dec;122:565-72
pubmed: 26436777
J Environ Sci (China). 2023 Mar;125:641-649
pubmed: 36375946
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782996
J Dairy Sci. 2018 Jun;101(6):5619-5628
pubmed: 29550113
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10420-10425
pubmed: 16803956
Sci Rep. 2018 Mar 1;8(1):3876
pubmed: 29497096
J Environ Manage. 2023 Apr 15;332:117413
pubmed: 36764214
J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):204-15
pubmed: 21899826
Front Microbiol. 2021 Oct 06;12:690942
pubmed: 34690943
J Hazard Mater. 2017 Feb 5;323(Pt A):177-183
pubmed: 27156397
Chest. 2012 Nov;142(5):1200-1210
pubmed: 22556319
PLoS One. 2014 Feb 13;9(2):e89059
pubmed: 24551218
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):135-144
pubmed: 34782783
Chemosphere. 2018 Jun;201:388-398
pubmed: 29529566
Gut Microbes. 2016 Nov;7(6):471-485
pubmed: 27624382
J Hazard Mater. 2018 Oct 15;360:623-630
pubmed: 30149349
Int J Environ Res Public Health. 2015 May 22;12(5):5657-84
pubmed: 26006133
FEMS Microbiol Lett. 1996 Jun 1;139(2-3):155-9
pubmed: 8674983
Gastroenterol Res Pract. 2013;2013:924769
pubmed: 24454344
J Toxicol Environ Health B Crit Rev. 2017;20(8):447-469
pubmed: 29182464
Environ Sci Technol. 2005 Mar 15;39(6):1420-6
pubmed: 15819193
Microb Pathog. 2011 Jul-Aug;51(1-2):1-8
pubmed: 21419838
Antimicrob Agents Chemother. 2012 Jun;56(6):3092-100
pubmed: 22430975
Microorganisms. 2022 Sep 05;10(9):
pubmed: 36144390
Physiol Res. 2020 Sep 30;69(Suppl 2):S211-S223
pubmed: 33094620
Caries Res. 2019;53(1):84-95
pubmed: 29961075
Biotechnol Rep (Amst). 2017 Apr 28;15:1-10
pubmed: 28580302
mBio. 2014 Apr 08;5(2):e01015
pubmed: 24713325
Appl Biochem Biotechnol. 2015 Sep;177(2):318-33
pubmed: 26201480
Int J Antimicrob Agents. 2016 Dec;48(6):680-689
pubmed: 27842757
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E152-E161
pubmed: 29269393
Environ Res. 2020 Apr;183:109288
pubmed: 32311914
Biochim Biophys Acta. 2002 Nov 14;1573(2):171-6
pubmed: 12399027
Sci Total Environ. 2021 Jul 15;778:146150
pubmed: 34030374
Gut Microbes. 2014 May-Jun;5(3):381-9
pubmed: 24690573
Environ Int. 2018 Dec;121(Pt 2):1217-1226
pubmed: 30389380
Healthcare (Basel). 2021 May 18;9(5):
pubmed: 34069956
Chemosphere. 2009 Aug;76(6):755-60
pubmed: 19535125

Auteurs

Audrey Thiroux (A)

Université de Poitiers, UMR CNRS 7267, Ecologie et Biologie des Interactions, Poitiers, France.

Jean-Marc Berjeaud (JM)

Université de Poitiers, UMR CNRS 7267, Ecologie et Biologie des Interactions, Poitiers, France.

Romain Villéger (R)

Université de Poitiers, UMR CNRS 7267, Ecologie et Biologie des Interactions, Poitiers, France.

Alexandre Crépin (A)

Université de Poitiers, UMR CNRS 7267, Ecologie et Biologie des Interactions, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH